Evidence map›Paper›PMID 19001088›Full record

ArticleMolecular and cellular biology2009

Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells.

Vladimir L Gabai, Julia A Yaglom, Todd Waldman, Michael Y Sherman

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Heat Shock Proteins and HSF1 in Cancer.Frontiers in oncology · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Vladimir L GabaiDepartment of Biochemistry, Boston University Medical School, 715 Albany St., Boston, Massachusetts 02118, USA.
Julia A Yaglom
Todd Waldman
Michael Y Sherman
Boston University · USGeorgetown University · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
HSP72 AND REGULATION OF STRESS KINASES IN TUMOR CELLSR01CA081244 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SHERMAN, MICHAEL Y · 2000 to 2013
$5.0M
A PTEN-Dependent Size Checkpoint in Human Cancer CellsR01CA115699 · NCI · GEORGETOWN UNIVERSITY · PI WALDMAN, TODD A · 2006 to 2016
$2.2M
NCI NIH HHS CA-081244NCI NIH HHS R01 CA081244NCI NIH HHS R01 CA115699
6 · The paper itself

Abstract

The heat shock protein Hsp72 is expressed at the elevated levels in various human tumors, and its levels often correlate with poor prognosis. Previously we reported that knockdown of Hsp72 in certain cancer cells, but not in untransformed breast epithelial cells, triggers senescence via p53-dependent and p53-independent mechanisms. Here we demonstrate that the p53-dependent pathway controlled by Hsp72 depends on the oncogenic form of phosphatidylinositol 3-kinase (PI3K). Indeed, upon expression of the oncogenic PI3K, epithelial cells began responding to Hsp72 depletion by activating the p53 pathway. Moreover, in cancer cell lines, activation of the p53 pathway caused by depletion of Hsp72 was dependent on oncogenes that activate the PI3K pathway. On the other hand, the p53-independent senescence pathway controlled by Hsp72 was associated with the Ras oncogene. In this pathway, extracellular signal-regulated kinases (ERKs) were critical for senescence, and Hsp72 controlled the ERK-activating kinase cascade at the level of Raf-1. Importantly, upon Ras expression, untransformed cells started responding to knockdown of Hsp72 by constitutive activation of ERKs, culminating in senescence. Therefore, Hsp72 is intimately involved in suppression of at least two separate senescence signaling pathways that are regulated by distinct oncogenes in transformed cells, which explains why cancer cells become "addicted" to this heat shock protein.

Indexed as

OncogenesSignal TransductionCell LineCell Line, TumorCellular SenescenceExtracellular Signal-Regulated MAP KinasesGene Knockdown TechniquesGenes, p53Genes, rasHSP72 Heat-Shock ProteinsHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-rafExtracellular Signal-Regulated MAP KinasesHSP72 Heat-Shock ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-raf

Identifiers

PMID19001088
PMCPMC2612502
OpenAlexW2104704977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.